Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Primary Health Care, Respiratory System, General & Internal Medicine, OBSTRUCTIVE PULMONARY-DISEASE, OVERLAP SYNDROME, PREVALENCE, ASTHMA, SMOKING, SIMPLER, Bronchodilator Agents, Cross-Sectional Studies, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Russia, Spirometry, Vital Capacity

Abstract:

A hallmark of the diagnosis of chronic obstructive pulmonary disease (COPD) is the measurement of post-bronchodilator (post-BD) airflow obstruction (AO) by spirometry, but spirometry is not enough for the provision of a clinical diagnosis. In the majority of previous epidemiological studies, COPD diagnosis has been based on spirometry and a few clinical characteristics. The aim of our study was to identify outcomes in patients newly diagnosed with airflow obstruction (AO) based on a diagnostic work-up conducted as part of a population-based cross-sectional study in North-Western Russia. Spirometry was performed before (pre-BD) and after BD administration, and AO was defined using the FEV1/FVC <0.70 and FEV1/FVC